ad

Nifty Pharma Prediction for Tomorrow (17 Nov 2026): Index Falls 1.53% From a Higher Open

16 Nov 2026 • 4:09 pm

Nifty Pharma Prediction for Tomorrow (17 Nov 2026): Index Falls 1.53% From a Higher Open

Quick Answer: The Nifty Pharma prediction for tomorrow is cautious for Tuesday, 17 November 2026. Nifty Pharma fell 1.53 percent to 28,098.40 on Monday, with first support near 27,792.93 and first resistance near 28,598.43. A hold above 27,792.93 keeps the setup steady, while a fall below it puts 27,487.47 in view.

Pharma was the weakest sector Univest tracked on Monday, with the index closing near the bottom of a wide range. This Nifty Pharma forecast for tomorrow is built from Monday's verified closing prices and is meant for the session on Tuesday, 17 November 2026.

Tuesday is also the weekly expiry day for Nifty options on NSE, which can widen intraday swings. Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are tracking US generic pricing and the Nifty 50 for the Nifty Pharma prediction for tomorrow.

Click Here – Get Free Investment Predictions

Nifty Pharma Prediction for Tomorrow: Key Levels for 17 Nov 2026

The Nifty Pharma prediction for tomorrow for Tuesday, 17 November 2026 uses classic pivot levels calculated from Monday's high of 28,793.00, low of 27,987.50 and close of 28,098.40, with support below the last price and resistance above it. These are the Nifty Pharma support and resistance levels Univest's analysts are watching.

Trend Support 1 Support 2 Resistance 1 Resistance 2
Bearish 27,792.93 27,487.47 28,598.43 29,098.47
Close Change Open High Low Previous close
28,098.40 -1.53% 28,596.15 28,793.00 27,987.50 28,535.75

Today's Market Recap

Monday's session sets the base for the Nifty Pharma prediction for tomorrow, and the points below show how the day unfolded.

  • Nifty Pharma fell 1.53 percent to 28,098.40 on Monday, opening above the previous close of 28,535.75 at 28,596.15 and closing about 111 points above its low of 27,987.50. It rose to 28,793.00, above the previous close of 28,535.75, but could not hold the gain. It fell while the Nifty 50 rose 0.58 percent, so it lagged the market.
  • Apollo Hospitals rose 2.87 percent on the same day, so hospitals moved opposite to drug makers.
  • The Nifty 50 rose 0.58 percent to 25,291.10 and the Sensex rose 0.63 percent to 82,104.79.
  • Sector moves were mixed. The Nifty FMCG index rose 1.87 percent and the Nifty IT index was almost flat at plus 0.03 percent, while the Nifty Pharma index fell 1.53 percent, the Nifty Metal index fell 1.50 percent and the Nifty Auto index fell 1.29 percent.
  • Most active among the stocks Univest tracked: HDFC Bank (about 27.1 million shares), Zee Entertainment (about 19.7 million) and ONGC (about 10.2 million).

Nifty Pharma Forecast for Tomorrow: Bull, Base and Bear Cases

The Nifty Pharma prediction for tomorrow can play out three ways on Tuesday, depending on whether the levels above hold.

  • Bullish case: A move and hold above 28,598.43 would point toward 29,098.47, with volume confirming the push.
  • Base case: Trade between 27,792.93 and 28,598.43 keeps the Nifty Pharma outlook for tomorrow range-bound, which Univest's analysts treat as the default if no fresh trigger appears.
  • Bearish case: A fall below 27,792.93 would bring 27,487.47 into focus and weaken the near-term tone.

What Is Driving the Nifty Pharma Outlook for Tomorrow

  • The index opened at 28,596.15, rose to 28,793.00 and then fell to a low of 27,987.50.
  • The fall of 1.53 percent was the largest among the sectors Univest tracked.
  • The Nifty 50 rose 0.58 percent, so pharma lagged the market by a wide margin.

Pharma stocks respond to US generic pricing, regulatory news and currency moves. Monday's specific trigger was not independently confirmed. The Nifty Pharma prediction for tomorrow therefore leans on the price data and the levels above.

Stocks and Triggers to Watch in the Nifty Pharma Space

Univest's analysts watch the large drug makers inside the index, along with US pricing commentary. Kunal Singla suggests that the group often trades on stock-specific news, so index moves can hide differences.

F&O and options context: For Tuesday's expiry, the Nifty options data shows a put-call ratio of approximately 0.94, with call open interest highest at the 25,500 strike and put open interest highest at the 25,000 strike. India VIX rose 1.29 percent to 15.70. Ankit Jaiswal suggests reading the Nifty Pharma outlook for tomorrow alongside these strikes, since expiry-day positioning can pull prices toward heavy open-interest zones.

These are educational views, not buy calls, and each should be checked against your own risk plan before acting.

Risks to the Nifty Pharma Prediction for Tomorrow

These are the main ways the Nifty Pharma prediction for tomorrow could turn out wrong.

  • A fresh regulatory or pricing headline can move the group quickly.
  • The close of 28,098.40 is about 111 points above the low, so a fresh low is possible.
  • A strong rupee can reduce export earnings for drug makers.

No level in this Nifty Pharma prediction for tomorrow is guaranteed to hold, and a single headline can invalidate it.

Analyst View: Ankit Jaiswal and Kunal Singla

On the Nifty Pharma prediction for tomorrow, Kunal Singla suggests that a close back above 28,535.75, Friday's close, would ease the pressure.

Ankit Jaiswal flags that the early rise to 28,793.00 followed by the fall to 27,987.50 shows heavy supply at higher levels.

Both analysts stress that the Nifty Pharma prediction for tomorrow is a view built on levels and data, not a forecast of returns.

Why This Is a Prediction for Tuesday

This Nifty Pharma prediction for tomorrow is published on Monday, 16 November 2026, after the close, using Monday's data, for the next trading session on Tuesday, 17 November 2026. Exchanges are open as usual on Tuesday.

Track the Nifty Pharma Space on Univest Screeners

Download the Univest iOS App or Univest Android App to get daily market recommendations and insightful research pieces.

Bottom Line for Tuesday's Session

The Nifty Pharma prediction for tomorrow leans cautious, with US pricing, regulation and the rupee as the variables to track. Ankit Jaiswal and Kunal Singla will revisit the view after Tuesday's opening trade.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the Nifty Pharma prediction for tomorrow?

Ans. The Nifty Pharma prediction for tomorrow is cautious for Tuesday, 17 November 2026. Nifty Pharma fell 1.53 percent to 28,098.40 on Monday, and Univest's analysts watch 27,792.93 as support and 28,598.43 as resistance.

What are the support and resistance levels for Nifty Pharma tomorrow?

Ans. For the Nifty Pharma prediction for tomorrow, support 1 is 27,792.93 and support 2 is 27,487.47, while resistance 1 is 28,598.43 and resistance 2 is 29,098.47. These are classic pivot levels calculated from Monday's high of 28,793.00, low of 27,987.50 and close of 28,098.40.

Why did Nifty Pharma fall on Monday?

Ans. The Nifty Pharma index fell on Monday after rising early to 28,793.00 and then dropping to 27,987.50, closing at 28,098.40. The specific trigger was not independently confirmed, so the move is best read through the price data: a high of 28,793.00, a low of 27,987.50 and a close of 28,098.40.

What will move Nifty Pharma on Tuesday?

Ans. US generic pricing, regulatory news, the rupee and the Nifty 50 are the usual drivers. Each of these feeds into the Nifty Pharma prediction for tomorrow for the session.

Is Nifty Pharma bullish or bearish for tomorrow?

Ans. The tone of the Nifty Pharma prediction for tomorrow is cautious, with the trend marked bearish. A hold above 27,792.93 keeps the setup steady, a close above 28,598.43 would strengthen it, and a fall below 27,792.93 would weaken it.

Is this a buy or sell call?

Ans. No. This is an educational outlook from Univest's research team, not a buy or sell call. Readers should check any view against their own risk plan, and past price moves do not guarantee future returns.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down